Gevo (GEVO) - 43.10% Below 52-Week High: Buy or Wait?

Stock Details

Gevo, Inc. (GEVO), a prominent company in the basic materials sector within the specialty chemicals industry, is based in United States and primarily trades on the NCM.Currently, the stock is trading at $1.69. Over the past 52 weeks, it has ranged between $1.37 and $2.97. This places the current price at 56.9% of its 52-week high and 23.4% above its 52-week low. Recent trading volume was recorded at 3,481,069. The 14-day Relative Strength Index (RSI) stands at 58.02, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $1.53 by 10.46%. Similarly, it is below its 200-day moving average of $1.91 by 11.52%. The MACD histogram is 0.01, indicating bullish momentum0. There is currently 1 active alert set for GEVO by users.

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Forward P/E

28.17

Price to Book

1.48

EV/EBITDA

-22.40

EPS (TTM)

-$0.90

Price to Sales

2.35

Beta

1.04

Similar volatility to market

Q:How is GEVO valued relative to its earnings and growth?

Valuation data is not available for this stock.

Q:What is GEVO's risk profile compared to the market?

With a beta of 1.04, Gevo, Inc. is roughly as volatile as the market, moving in line with broad market trends. This moderate beta suggests the stock offers market-level returns without excessive volatility. The price-to-book ratio of 1.48 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

-119.93%

Operating Margin

-76.79%

EBITDA

$-23,434,000

Return on Equity

-55.53%

Return on Assets

-5.19%

Revenue Growth (YoY)

7.10%

Q:How profitable and efficient is GEVO's business model?

Gevo, Inc. achieves a profit margin of -119.93%, meaning it retains $-119.93 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of -76.79% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at -55.53% and ROA at -5.19%, the company achieves moderate returns on invested capital.

Q:What are GEVO's recent growth trends?

Gevo, Inc.'s revenue grew by 7.10% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. These growth metrics should be evaluated against Specialty Chemicals industry averages for proper context.

Company Size & Market

Market Cap

$417.8M

Revenue (TTM)

$177.51M

Revenue/Share (TTM)

$0.75

Shares Outstanding

247.24M

Book Value/Share

$1.14

Asset Type

EQUITY

Q:What is GEVO's market capitalization and position?

Gevo, Inc. has a market capitalization of $417.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 247.24M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Specialty Chemicals industry, it competes with other firms in this sector.

Q:How does GEVO's price compare to its book value?

Gevo, Inc.'s book value per share is $1.14, while the current stock price is $1.69, resulting in a price-to-book (P/B) ratio of 1.48. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$5.39

218.79% upside potential

Analyst Recommendations

Strong Buy

Buy

Hold

Sell

Strong Sell

Q:How reliable are analyst predictions for GEVO?

4 analysts cover GEVO with 50% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The mixed views reflect uncertainty about the outlook. The consensus target of $5.39 implies 218.8% upside, but targets are often adjusted to follow price moves rather than predict them.

Q:What is the Wall Street consensus on GEVO?

Current analyst recommendations:02 Buy, 2 Hold, 00The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Aug 15, 2026, 02:21 AM

Technical Indicators

RSI (14-day)

58.02

Neutral

50-Day Moving Average

$1.53

10.46% above MA-50

200-Day Moving Average

$1.91

-11.52% below MA-200

MACD Line

0.02

MACD Signal

N/A

MACD Histogram

0.01

Bullish

Q:What does GEVO's RSI value tell investors?

The RSI (Relative Strength Index) for GEVO is currently 58.02, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.

Q:How should traders interpret GEVO's MACD and moving average crossovers?

MACD analysis shows the MACD line at 0.02 above the signal line at 0.00, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($1.53) is below the 200-day MA ($1.91), forming a death cross pattern that often warns of extended weakness. Price is currently between the MAs, suggesting transition.

Indicators last updated: Aug 15, 2026, 12:51 AM

Condition	Threshold	Created At
Reaches new 52-week high	N/A	Jan 30, 2026, 04:36 PM

Condition

Threshold

Created At

Reaches new 52-week high

N/A

Jan 30, 2026, 04:36 PM

Gevo, Inc. (GEVO) Stock